Additional Royalties. In addition to the royalties set forth in Section 4.1, Luitpold agrees to pay to BMPI ** of any license fees and milestone payments other than payments in respect of or measured by Net Sales, received by Luitpold or any Affiliate from ** for rights to distribute the Licensed Products to U.S. hospitals and surgical centers for the repair, restoration or reconstruction of cranio-maxillofacial osseous defects.
Appears in 3 contracts
Sources: Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.), Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.), Exclusive Sublicense Agreement (Biomimetic Therapeutics, Inc.)